Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ABT-493
.
Show all posts
Showing posts with label
ABT-493
.
Show all posts
Monday, July 11, 2016
AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs
›
ABT-493 ABT-530 ribavirin (RBV AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) o...
›
Home
View web version
